{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:16:57Z","timestamp":1792603017970,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02319","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T05:02:46Z","timestamp":1569906166000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide"],"prefix":"10.3389","volume":"10","author":[{"given":"Raffaella","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Nitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Lupo Stanghellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mastaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Assanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marktel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41409-018-0153-1","article-title":"Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report","volume":"53","author":"Passweg","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MOH.0b013e32833eaf1b","article-title":"High-dose cyclophosphamide for graft-versus-host disease prevention","volume":"17","author":"Luznik","year":"2010","journal-title":"Curr Opin Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/17474086.2017.1318054","article-title":"Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?","volume":"10","author":"Mussetti","year":"2017","journal-title":"Expert Rev Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3324\/haematol.2016.151779","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant","volume":"102","author":"Ruggeri","year":"2017","journal-title":"Haematologica."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1016\/j.bbmt.2011.10.019","article-title":"Clinical applications for biomarkers of acute and chronic graft-versus-host disease","volume":"18","author":"Levine","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E3528","DOI":"10.3390\/ijms19113528","article-title":"The two-faced cytokine IL-6 in host defense and diseases","volume":"19","author":"Narazaki","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/ijms17111823","article-title":"Pretransplant levels of CRP and interleukin-6 family cytokines; effects on outcome after allogeneic stem cell transplantation","volume":"17","author":"Tvedt","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fimmu.2017.00667","article-title":"Interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target","volume":"8","author":"Tvedt","year":"2017","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bcp.2015.06.009","article-title":"Biological effects of interleukin-6: clinical applications in autoimmune diseases and cancers","volume":"97","author":"Ho","year":"2015","journal-title":"Biochem Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","article-title":"Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation","volume":"103","author":"Casper","year":"2004","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/leu.2014.180","article-title":"Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors","volume":"29","author":"Peccatori","year":"2015","journal-title":"Leukemia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","article-title":"Post-transplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells","volume":"21","author":"Cieri","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood-2016-06-723205","article-title":"Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation","volume":"128","author":"Greco","year":"2016","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation."},{"key":"B20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"B25","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat."},{"key":"B27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbmt.2016.04.022","article-title":"The role of biomarkers in the diagnosis and risk stratification of acute graft-versus-host disease: a systematic review","volume":"22","author":"Ali","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbmt.2008.10.027","article-title":"Plasma biomarkers in graft-versus-host disease: a new era?","volume":"15","author":"Paczesny","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1182\/blood-2012-08-355990","article-title":"Discovery and validation of graft-versus-host disease biomarkers","volume":"121","author":"Paczesny","year":"2013","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.4049\/jimmunol.1500117","article-title":"Cytokines in graft-versus-host disease","volume":"194","author":"Henden","year":"2015","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fimmu.2016.00539","article-title":"Danger signals and graft-versus-host disease: current understanding and future perspectives","volume":"7","author":"Toubai","year":"2016","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/cei.13124","article-title":"A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation","volume":"193","author":"Tvedt","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e89798","DOI":"10.1172\/jci.insight.124015","article-title":"An early-biomarker algorithm predicts lethal graft-versus-host disease and survival","volume":"3","author":"Hartwell","year":"2018","journal-title":"JCI Insight."},{"key":"B38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00007890-199209000-00014","article-title":"The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation","volume":"54","author":"Symington","year":"1992","journal-title":"Transplantation."},{"key":"B39","first-page":"331","article-title":"Serum cytokine levels in patients undergoing bone marrow transplantation","volume":"12","author":"Chasty","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"B40","first-page":"635","article-title":"Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation","volume":"12","author":"Rowbottom","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"B41","first-page":"745","article-title":"Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease","volume":"13","author":"Imamura","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"B42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1703258","article-title":"The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Min","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1182\/blood-2015-03-636753","article-title":"Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment","volume":"126","author":"Mcdonald","year":"2015","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2014-07-590232","article-title":"Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation","volume":"125","author":"Varelias","year":"2015","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2009-01-197178","article-title":"Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease","volume":"114","author":"Chen","year":"2009","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1470-2045(14)71017-4","article-title":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1\/2 trial","volume":"15","author":"Kennedy","year":"2014","journal-title":"Lancet Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/10428194.2015.1045896","article-title":"Tocilizumab for steroid refractory acute graft-versus-host disease","volume":"57","author":"Roddy","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3324\/haematol.2017.183434","article-title":"Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease","volume":"103","author":"Drobyski","year":"2018","journal-title":"Haematologica."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1182\/blood-2006-12-041889","article-title":"How I treat refractory acute GVHD","volume":"109","author":"Deeg","year":"2007","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1182\/blood-2013-12-543736","article-title":"Activity of therapeutic JAK 1\/2 blockade in graft-versus-host disease","volume":"123","author":"Spoerl","year":"2014","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T22:01:49Z","timestamp":1611439309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2019.02319"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02319","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"article-number":"2319"}}